185 related articles for article (PubMed ID: 23868108)
1. Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.
Sana G; Dragon-Durey MA; Charbit M; Bouchireb K; Rousset-Rouvière C; Bérard E; Salomon R; Frémeaux-Bacchi V; Niaudet P; Boyer O
Pediatr Nephrol; 2014 Jan; 29(1):75-83. PubMed ID: 23868108
[TBL] [Abstract][Full Text] [Related]
2. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
[TBL] [Abstract][Full Text] [Related]
3. Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome.
Khandelwal P; Gupta A; Sinha A; Saini S; Hari P; Dragon Durey MA; Bagga A
Pediatr Nephrol; 2015 Mar; 30(3):451-7. PubMed ID: 25217328
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of children with anti-CFH autoantibody-associated hemolytic uremic syndrome: a report of 8 cases.
Li Q; Kong X; Tian M; Wang J; Yang Z; Yu L; Liu S; Wang C; Wang X; Sun S
Ren Fail; 2022 Dec; 44(1):1061-1069. PubMed ID: 35730179
[TBL] [Abstract][Full Text] [Related]
5. Anti-Factor H Antibody-Associated Atypical Hemolytic Uremic Syndrome: A Case Report.
Abazi-Emini N; Sahpazova E; Putnik J; Tasic V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Oct; 42(2):109-115. PubMed ID: 34699711
[No Abstract] [Full Text] [Related]
6. Successful treatment of DEAP-HUS with eculizumab.
Noone D; Waters A; Pluthero FG; Geary DF; Kirschfink M; Zipfel PF; Licht C
Pediatr Nephrol; 2014 May; 29(5):841-51. PubMed ID: 24249282
[TBL] [Abstract][Full Text] [Related]
7. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.
Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Guo WY; Wang SX; Yu F; Zhao MH;
Pediatr Nephrol; 2017 May; 32(5):811-822. PubMed ID: 28035470
[TBL] [Abstract][Full Text] [Related]
8. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
Hofer J; Janecke AR; Zimmerhackl LB; Riedl M; Rosales A; Giner T; Cortina G; Haindl CJ; Petzelberger B; Pawlik M; Jeller V; Vester U; Gadner B; van Husen M; Moritz ML; Würzner R; Jungraithmayr T;
Clin J Am Soc Nephrol; 2013 Mar; 8(3):407-15. PubMed ID: 23243267
[TBL] [Abstract][Full Text] [Related]
9. Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome.
Strobel S; Hoyer PF; Mache CJ; Sulyok E; Liu WS; Richter H; Oppermann M; Zipfel PF; Józsi M
Nephrol Dial Transplant; 2010 Jan; 25(1):136-44. PubMed ID: 19666655
[TBL] [Abstract][Full Text] [Related]
10. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
[TBL] [Abstract][Full Text] [Related]
11. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
Sinha A; Gulati A; Saini S; Blanc C; Gupta A; Gurjar BS; Saini H; Kotresh ST; Ali U; Bhatia D; Ohri A; Kumar M; Agarwal I; Gulati S; Anand K; Vijayakumar M; Sinha R; Sethi S; Salmona M; George A; Bal V; Singh G; Dinda AK; Hari P; Rath S; Dragon-Durey MA; Bagga A;
Kidney Int; 2014 May; 85(5):1151-60. PubMed ID: 24088957
[TBL] [Abstract][Full Text] [Related]
12. Atypical hemolytic uremic syndrome due to factor H autoantibody.
Uslu-Gökceoğlu A; Doğan CS; Comak E; Koyun M; Akman S
Turk J Pediatr; 2013; 55(1):86-9. PubMed ID: 23692839
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of renal transplant in patients with anti-complement factor H antibody-associated hemolytic uremic syndrome.
Khandelwal P; Sinha A; Hari P; Bansal VK; Dinda AK; Bagga A
Pediatr Transplant; 2014 Aug; 18(5):E134-9. PubMed ID: 24814615
[TBL] [Abstract][Full Text] [Related]
14. Early relapse rate determines further relapse risk: results of a 5-year follow-up study on pediatric CFH-Ab HUS.
Hofer J; Riedl Khursigara M; Perl M; Giner T; Rosales A; Cortina G; Waldegger S; Jungraithmayr T; Würzner R
Pediatr Nephrol; 2021 Apr; 36(4):917-925. PubMed ID: 33025207
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.
Puraswani M; Khandelwal P; Saini H; Saini S; Gurjar BS; Sinha A; Shende RP; Maiti TK; Singh AK; Kanga U; Ali U; Agarwal I; Anand K; Prasad N; Rajendran P; Sinha R; Vasudevan A; Saxena A; Agarwal S; Hari P; Sahu A; Rath S; Bagga A
Front Immunol; 2019; 10():1282. PubMed ID: 31231391
[No Abstract] [Full Text] [Related]
16. Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome.
Guo WY; Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Wang SX; Yu F; Zhao MH;
Pediatr Nephrol; 2019 Feb; 34(2):269-281. PubMed ID: 30315407
[TBL] [Abstract][Full Text] [Related]
17. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.
Waters AM; Pappworth I; Marchbank K; Bockenhauer D; Tullus K; Pickering MC; Strain L; Sebire N; Shroff R; Marks SD; Goodship TH; Rees L
Am J Transplant; 2010 Jan; 10(1):168-72. PubMed ID: 19951285
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristies of atypical hemolytie uremic syndrome associated with H factor antibody in children].
Guan N; Liu X; Yao Y; Yang J; Wang F; Xiao H; Ding J; Zhao M; Yu F; Wang F
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):223-6. PubMed ID: 24824395
[TBL] [Abstract][Full Text] [Related]
19. Rituximab to Abbreviate Plasma Exchange in Anti-CFH (Complement Factor H) Antibody Mediated Atypical HUS.
Mittal A; Dijoo M; Aggarwal S; Gulati S
Iran J Kidney Dis; 2019 Mar; 13(2):134-138. PubMed ID: 30988252
[TBL] [Abstract][Full Text] [Related]
20. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
